Replies to post #399749 on Anavex Life Sciences Corp (AVXL)

[RedShoulder]

I do not agree, these are failing results:

"ADAS-Cog11 scores changed from 19.1 (±9.2) to 19.6 (±13.3)"

"In the moderate sub-group, ADAS-Cog scores worsened, from 25.7 (±9.2) to 30.1 (±13.1)"

Wouldn’t call it a failure. Just not nearly as impressive as the combined arm of Blarcamesine.

The market agrees that the data is not good. 28.25 down -8.19 and loss -22.49%
As of 11:29AM EST. Market open.